CUAMC
PLRX icon

China Universal Asset Management Company’s Pliant Therapeutics PLRX Stock Holding History

China Universal Asset Management Company’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,760
Closed -$15.9K – 522
2025
Q3 		$15.9K Sell
10,760
-1,569
-13% -$2.39K ﹤0.01% 465
2025
Q2 		$14.3K Buy
12,329
+123
+1% +$174 ﹤0.01% 457
2025
Q1 		$16.5K Sell
12,206
-697
-5% -$4.23K ﹤0.01% 461
2024
Q4 		$170K Buy
12,903
+1,209
+10% +$16.5K 0.02% 338
2024
Q3 		$131K Buy
11,694
+4,607
+65% +$57.6K 0.01% 334
2024
Q2 		$76.2K Sell
7,087
-4,494
-39% -$57.9K 0.01% 320
2024
Q1 		$173K Buy
11,581
+4,652
+67% +$76.7K 0.02% 310
2023
Q4 		$125K Buy
6,929
+5,400
+353% +$82.1K 0.02% 253
2023
Q3 		$26.5K Buy
1,529
+754
+97% +$13.1K 0.01% 279
2023
Q2 		$14K Buy
775
+2
+0.3% +$47 ﹤0.01% 298
2023
Q1 		$20.6K Buy
773
+278
+56% +$7.92K 0.01% 217
2022
Q4 		$9.57K Buy
495
+39
+9% +$815 ﹤0.01% 231
2022
Q3 		$10K Buy
+456
New +$8.72K ﹤0.01% 207

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

China Universal Asset Management Company's PLRX Position: Q4 2025 in Review

China Universal Asset Management Company sold out of Pliant Therapeutics (PLRX) in Q4 2025, closing a stake of 10,760 shares — an estimated $15.9K sold.

China Universal Asset Management Company first reported a position in PLRX in Q3 2022 and held it in 13 quarters. The position peaked at $173K in Q1 2024. 97 funds tracked by Wall St. Rank hold PLRX as of Q4 2025.

  • China Universal Asset Management Company reported no remaining Pliant Therapeutics position as of Q4 2025 after selling out during the quarter.
  • China Universal Asset Management Company sold 10,760 Pliant Therapeutics shares in Q4 2025, an estimated $15.9K.
  • China Universal Asset Management Company first reported a position in Pliant Therapeutics in Q3 2022 and held it in 13 quarters.
  • China Universal Asset Management Company's Pliant Therapeutics position peaked at $173K in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2025.

Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.